254 related articles for article (PubMed ID: 34575463)
1. Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy.
Han JW; Yoon SK
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575463
[TBL] [Abstract][Full Text] [Related]
2. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC.
Biondetti P; Saggiante L; Ierardi AM; Iavarone M; Sangiovanni A; Pesapane F; Fumarola EM; Lampertico P; Carrafiello G
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830949
[TBL] [Abstract][Full Text] [Related]
3. The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma.
Singh P; Toom S; Avula A; Kumar V; Rahma OE
J Hepatocell Carcinoma; 2020; 7():11-17. PubMed ID: 32104669
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.
Craciun L; de Wind R; Demetter P; Lucidi V; Bohlok A; Michiels S; Bouazza F; Vouche M; Tancredi I; Verset G; Garaud S; Naveaux C; Galdon MG; Gallo KW; Hendlisz A; Derijckere ID; Flamen P; Larsimont D; Donckier V
BMC Cancer; 2020 Feb; 20(1):135. PubMed ID: 32075608
[TBL] [Abstract][Full Text] [Related]
5. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy.
Duan Y; Zhang H; Tan T; Ye W; Yin K; Yu Y; Kang M; Yang J; Liao R
Biosci Trends; 2024 Jan; 17(6):427-444. PubMed ID: 37981319
[TBL] [Abstract][Full Text] [Related]
6. Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns.
Park W; Chung YH; Kim JA; Jin YJ; Lee D; Shim JH; Lee D; Kim KM; Lim YS; Lee HC; Lee YS; Kim PN; Sung KB
Hepatol Res; 2013 Dec; 43(12):1304-12. PubMed ID: 23442052
[TBL] [Abstract][Full Text] [Related]
7. Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.
Young S; Taylor AJ; Sanghvi T
J Clin Transl Hepatol; 2018 Jun; 6(2):189-197. PubMed ID: 29951364
[TBL] [Abstract][Full Text] [Related]
8. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study.
Yan L; Ren Y; Qian K; Kan X; Zhang H; Chen L; Liang B; Zheng C
BMC Gastroenterol; 2021 Apr; 21(1):182. PubMed ID: 33879085
[TBL] [Abstract][Full Text] [Related]
9. New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma.
Liu H; Wang C; Wang R; Cao H; Cao Y; Huang T; Lu Z; Xiao H; Hu M; Wang H; Zhao J
Chin J Cancer Res; 2024 Apr; 36(2):167-194. PubMed ID: 38751435
[TBL] [Abstract][Full Text] [Related]
10. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349
[TBL] [Abstract][Full Text] [Related]
12. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
[TBL] [Abstract][Full Text] [Related]
13. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
Xu Z; Xie H; Zhou L; Chen X; Zheng S
Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation.
Wang X; Liang H; Lu Z
Minim Invasive Ther Allied Technol; 2020 Dec; 29(6):344-352. PubMed ID: 31375044
[No Abstract] [Full Text] [Related]
15. Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.
Chen JJ; Jin ZC; Zhong BY; Fan W; Zhang WH; Luo B; Wang YQ; Teng GJ; Zhu HD
United European Gastroenterol J; 2024 Mar; 12(2):226-239. PubMed ID: 38372444
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y
Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
[TBL] [Abstract][Full Text] [Related]
18. Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.
Lee DH; Lee JM; Kim PN; Jang YJ; Kang TW; Rhim H; Seo JW; Lee YJ
Eur Radiol; 2019 Sep; 29(9):5052-5062. PubMed ID: 30770968
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy.
Kim W; Cho SK; Shin SW; Hyun D; Lee MW; Rhim H
Abdom Radiol (NY); 2019 Jun; 44(6):2283-2292. PubMed ID: 30806742
[TBL] [Abstract][Full Text] [Related]
20. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
